Nanosensitizer for Cancer Radioimmunotherapy via Anti‐IL‐35 Blockade Boosted Innate Immunity Activation
Open Access
- 26 June 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (36) , e04252
Abstract
The cGAS‐STING signaling pathway has emerged as a promising target for cancer immunotherapy. However, STING agonists have a dual‐edged nature. Although they enhance antitumor T cell activity, STING agonists also elicit protumorigenic effects by promoting IL‐35‐producing B regulatory (Breg) cells, suppressing natural killer (NK) cell density, and fostering immune suppression. To address these challenges, this work develops a tumor microenvironment‐responsive hollow mesoporous nanosystem that degrades under high glutathione conditions, thereby releasing the STING agonist MSA‐2 and Mn ions. This nanosystem facilitates magnetic resonance imaging‐guided chemodynamic therapy and radiosensitization, efficiently activating the cGAS‐STING pathway by disrupting mitochondrial and nuclear DNA. Notably, by integrating this nanosystem with an anti‐IL‐35 blockade, this work successfully mitigates the Breg cell‐mediated suppression of NK cells, restores innate immune responses, and enhances antitumor efficacy. This study highlights the pivotal role of anti‐IL‐35 in reversing immunosuppression, enhancing innate immunity, and establishing a synergistic theranostic platform for molecular imaging‐guided cancer radioimmunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (82072056)
- National Natural Science Foundation of China (82302140)
- National Natural Science Foundation of China (51937010)
- National Natural Science Foundation of China (82271987)
- National Natural Science Foundation of China (82271939)
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515011882)
This publication has 50 references indexed in Scilit:
- STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapyBioactive Materials, 2024
- Multifunctional Mesoporous Polydopamine‐Based Systematic Delivery of STING Agonist for Enhanced Synergistic Photothermal‐ImmunotherapyAdvanced Functional Materials, 2023
- cGAS‐STING signaling in cancer: Regulation and therapeutic targetingMedComm – Oncology, 2023
- Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor EfficacyAdvanced Materials, 2023
- Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune CellsAdvanced Materials, 2022
- Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor‐Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer ImmunotherapyAdvanced Materials, 2022
- A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer ImmunotherapyAdvanced Materials, 2022
- High‐Z‐Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor VaccinationAdvanced Materials, 2022
- ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer ImmunotherapyAdvanced Materials, 2021
- Actively Targeted Deep Tissue Imaging and Photothermal‐Chemo Therapy of Breast Cancer by Antibody‐Functionalized Drug‐Loaded X‐Ray‐Responsive Bismuth Sulfide@Mesoporous Silica Core–Shell NanoparticlesAdvanced Functional Materials, 2017